Roflumilast, ursodeoxycholic acid and nucleinate efficiency in patients with chronic obstructive pulmonary disease with accompanying chronic non-stone cholecystitis

Journal Title: Медичні перспективи - Year 2014, Vol 19, Issue 4

Abstract

Global Initiative for diagnosis, treatment and prevention of COPD has recently included roflumilast (R) - an inhibitor of phosphodiesterase-4 (PDE-4) as a new therapeutic agent to the recommendations for the management of patients suffering from COPD with severe and moderate course. Objective. To investigate the efficacy of roflumilast, ursodeoxycholic and ribonucleinic acids in patients with COPD with an accompanying chronic non-stone cholecystitis. Materials and methods. The study involved 40 patients with COPD stage II-III, in the acute phase with an accompanying CNC in the acute phase and 20 practically healthy individuals (PHI). Patients of the control group (group 2) received berodual, UA500 mg overnight for 30 days, under the conditions of infective exacerbation of COPD - antibiotic therapy. Group 1 (study, 20 people) received roflumilast 500 mg additionally once a day, nucleinas 500 mg 3 times daily for 30 days. Results and discussion. The results obtained in the study of the dynamics of treatment and their analysis indicate that exposure to complex therapy, amelioration, reducing the signs of exacerbation of COPD and CNC, a significant improvement of quality of life in patients of group 1 were noticed sooner. Figures of external respiration functions(FER) in dynamics of treatment in patients with COPD with an accompanying CNC show higher efficiency of the proposed therapy too. In particular, the rate of forced expiration for the first second after treatment in patients of group 1 increased by 31,5% (p<0,05), while patients in group 2 - by 14,0% (p<0,05) probable presence of intergroup differences (p<0,05). Taking into consideration the fact that the treatment of patients of group 1 included antioxidant preparation H - dynamic performance and the intensity of lipid peroxidation were significantly different from baseline in all periods of observation. For instance, the content of MA (malonic aldehyde) in plasma after treatment in group 1 decreased by 1,7 times (p<0,05), while in group 2 - 1,2 times (p<0,05) with significant difference between groups (p<0,05). Biochemical analysis of blood and bile for bilirubin after treatment indicates its significant reduction in patients of group 1 - by 1,7 times in blood (p<0,05) and 27,7% (p<0,05) in bile.In patients of group 2, due to the influence of the UA, bilirubin in bile decreased by 7,8% (p<0,05), and the content of bilirubin in blood decreased by 13,0% (p<0,05). Conclusions. The use of roflumilast in combination with berodual, ursodeoxycholic and ribonucleinic acids in patients with COPD and in acute CNC promoted faster, than under conventional therapy (6-7 days), elimination of symptoms of both acute comorbid conditions. Combined therapy of patients with COPD stage II-III of the CNC in the acute phase, which included inhalation therapy with berodual, ursodeoxycholic acid, roflumilast and nuclineas helped to reduce the intensity of oxidative stress, endotoxemia, renewed the activity of the components with antioxidant protection and natural detoxification system.

Authors and Affiliations

T. Dudka, O. Huhlina

Keywords

Related Articles

Захворюваність на саркоїдоз органів дихання в південному та північному регіонах України

Проведено сравнительное изучение заболеваемости и распространенности саркоидоза органов дыхания в южном (АР Крым) и северном (Житомирская область) регионах Украины по данным обращаемости и результатам профилактического р...

Клінічний випадок виразкової хвороби дванадцятипалої кишки з перфорацією у породіллі після планового кесаревого розтину

Язвенная болезнь желудка или двенадцатиперстной кишки с перфорацией - тяжелое, угрожающее смертью осложнение язвенной болезни, особенно у беременных или в послеродовом периоде. Возникновение данного осложнения в послерод...

 Effect of frequent consumption of alcohol on the state of skin and general health state of males

 The objective of the study was to determine the effect of frequent consumption of alcohol on the state of skin and general health state of males. 197 males aged 45-64 years have been examined. They have been divid...

HLA DRB1 поліморфізм та ризик виникнення ко-інфекції ВІЛ/туберкульоз

HLA DRB1 полиморфизм и риск возникновения ко-инфекции ВИЧ/туберкулез. Шостакович-Корецкая Л.Р., Воликова О.А., Литвин Е.Ю., Губарь И.А., Кушнерова Е.А., Шевелева Е.В. В работе пред­ставлены данные изучения взаимосвязи ме...

Распространённость и интенсивность основных стоматологических заболеваний у детей г. Симферополя

На сьогодні, незважаючи на наявність сучасних ефективних засобів гігієни порожнини рота і профілактики стоматологічних захворювань, що дозволили знизити їх інтенсивність, поширеність захворювань залишається дуже високою....

Download PDF file
  • EP ID EP147744
  • DOI -
  • Views 112
  • Downloads 0

How To Cite

T. Dudka, O. Huhlina (2014). Roflumilast, ursodeoxycholic acid and nucleinate efficiency in patients with chronic obstructive pulmonary disease with accompanying chronic non-stone cholecystitis. Медичні перспективи, 19(4), 43-49. https://europub.co.uk./articles/-A-147744